Merck logoMerck

Overview Powered by AI

Merck, a global powerhouse in healthcare, fuels Africa's startup ecosystem through its Grant rounds. Supporting companies like RxAll, Merck's unique focus on health innovation sets them apart. Their unwavering commitment to improving healthcare outcomes for all Africans makes them a beacon of progress in the investment landscape.

Type
Private Equity

Merck's Portfolio in Africa

Merck has made over 1 notable investments in African startups. Their most recent investment was in RxAll, announced on August 31st, 2017.
Merck's Latest news
Germany's Merck KGaA insists chip market remains attractive - Reuters

Cancer Monoclonal Antibodies Market Report 2022: Featuring AbbVie, Bristol-Myers Squibb, Eli Lilly, Pfizer, Novartis, Merck & More - GlobeNewswire

Drugmaker Merck: placed under formal investigation in France over Levothyrox - Reuters.com

Thinking about trading options or stock in Merck, Tesla, Advanced Micro Devices, Salesforce, or Atlassian? - PR Newswire

Merck's Investment activity in Africa

With over $60K invested in African startups, their latest investment was a Grant round in RxAll, announced on August 31st, 2017, closing at $60K.

Here are some of their investments in Africa:

RoundStartupLocationDateAmount Raised
Grant
RxAll
NigeriaAug 31, 2017$ 60,000
Seed
VendEase
NigeriaMar 23, 2021$ 125,000
Seed
VendEase
NigeriaMar 23, 2021$ 125,000
Seed
VendEase
NigeriaMar 23, 2021$ 125,000
Seed
VendEase
NigeriaMar 23, 2021$ 125,000
Seed
VendEase
NigeriaMar 23, 2021$ 125,000

Upgrade to StartupList Africa PRO for unlimited access to this list.

Unlock Access to Full List

Merck's Investment Distribution in Africa.

Merck's currently has Startuup investments spread across the following location(s)

Unlock more Data

Access more Data and functionalities with our PRO plan.